These effects, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 aid the notion of focusing on ACKR3 as a novel approach to modulate the opioid system, which could open new therapeutic avenues for opioid-associated Problems. “In general, the invention of https://sethrdndk.link4blogs.com/55657952/conolidine-an-overview